Cited by 911Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Statins: mechanism of action and effects

Open access

Stancu, Camelia, Sima, Anca·2001·Journal of Cellular and Molecular Medicine

DOI 10.1111/j.1582-4934.2001.tb00172.xPMC PMC6740083

Open this paper in CoChat — free account Open PDF

Abstract

The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2001.tb00172.x

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Coronary Plaque Disruption
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors: Similarities and Differences
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512

Show all 42 references

Research works printed but not linked: 2

Voet D., 1995, Biochemistry, 315
StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).

Sorted by citations

Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 850
Biosynthesis of isoprenoids via the non-mevalonate pathway
Eisenreich, W., Bacher, A., Arigoni, D., & Rohdich, F. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3381-z · Cited by 692
Myocardial ischemia-reperfusion injury and the influence of inflammation
Algoet, M., Janssens, S. P., Himmelreich, U., Gsell, W., Pusovnik, M., den Eynde, J. V., & Oosterlinck, W. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.02.005 · Cited by 571
Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries
Bezerra, F. S., Lanzetti, M., Nesi, R. T., Nagato, A. C., Silva, C. P. E., Kennedy-Feitosa, E., Melo, A. C., Cattani‐Cavalieri, I., Pôrto, L. C., & Valença, S. S. (2023) · Antioxidants · doi:10.3390/antiox12030548 · Cited by 373
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 355
Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-activeLactobacillus reuteriNCIMB 30242 yoghurt formulation in hypercholesterolaemic adults
Jones, M. L., Martoni, C., Parent, M., & Prakash, S. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004703 · Cited by 331
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control
Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 302
Vascular endothelium in atherosclerosis
Sima, A. V., Stancu, C. S., & Simionescu, M. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0678-5 · Cited by 272
Self-citation
PCSK9 inhibitors: A new era of lipid lowering therapy
Chaudhary, R., Garg, J., Shah, N., & Sumner, A. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i2.76 · Cited by 299
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 289
Effects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 270
Statin drugs to reduce breast cancer recurrence and mortality
Beckwitt, C. H., Brufsky, A., Oltvai, Z. N., & Wells, A. H. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1066-z · Cited by 197
Lipids in the cell: organisation regulates function
Santos, A. L., & Preta, G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2765-4 · Cited by 197
Hypercholesterolemia and microvascular dysfunction: interventional strategies
Stapleton, P. A., Goodwill, A. G., James, M. E., Brock, R. W., & Frisbee, J. C. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-54 · Cited by 192
Simvastatin Therapy Reduces Prooxidant‐Antioxidant Balance: Results of a Placebo‐Controlled Cross‐Over Trial
Parizadeh, S. M. R., Azarpazhooh, M. R., Moohebati, M., Nematy, M., Ghayour‐Mobarhan, M., Tavallaie, S., Rahsepar, A. A., Amini, M., Sahebkar, A., Mohammadi, M., et al. (2011) · Lipids · doi:10.1007/s11745-010-3517-x · Cited by 182
Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
Kim, J., Lee, H., An, J., Song, Y., Lee, C., Kim, K., & Kong, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01947 · Cited by 164
Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
Galper, J., Dean, N. J., Pickford, R., Lewis, S. J. G., Halliday, G. M., Kim, W. S., & Dzamko, N. L. (2022) · Brain · doi:10.1093/brain/awac176 · Cited by 168
Membrane Lipid Organization Is Critical for Human Neutrophil Polarization
Pierini, L. M., Eddy, R. J., Fuortes, M., Seveau, S. M., Casulo, C., & Maxfield, F. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212386200 · Cited by 152
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
Brown, D. N., Caffa, I., Cirmena, G., Piras, D., Garuti, A., Gallo, M., Alberti, S., Nencioni, A., Ballestrero, A., & Zoppoli, G. M. (2016) · Scientific Reports · doi:10.1038/srep19435 · Cited by 150
Current and Emerging Uses of Statins in Clinical Therapeutics: A Review
Davies, J. T., Delfino, S., Feinberg, C. E., Johnson, M. F., Nappi, V. L., Olinger, J. T., Schwab, A., & Swanson, H. I. (2016) · Lipid Insights · doi:10.4137/lpi.s37450 · Cited by 156
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells
Perucha, E., Melchiotti, R., Bibby, J. A., Wu, W. H., Frederiksen, K. S., Roberts, C. A., Hall, Z., Friec, G. L., Robertson, K. A., Lavender, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08332-9 · Cited by 132
Polychlorinated biphenyls and links to cardiovascular disease
Perkins, J. T., Petriello, M. C., Newsome, B. J., & Hennig, B. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-4479-6 · Cited by 132
Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors
Hasheminasabgorji, E., & Jha, J. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111602 · Cited by 126
Recent developments in self-resistance gene directed natural product discovery
Yan, Y., Liu, N., & Tang, Y. (2020) · Natural Product Reports · doi:10.1039/c9np00050j · Cited by 120
New Insights Into Targeting Membrane Lipids for Cancer Therapy
Preta, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.571237 · Cited by 132
Management of diabetic dyslipidemia: An update
Jialal, I., & Singh, G. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.280 · Cited by 128
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
Giacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 121
Lipid Metabolism and Resistance to Anticancer Treatment
Germain, N., Dhayer, M., Boileau, M., Fovez, Q., Kluza, J., & Marchetti, P. (2020) · Biology · doi:10.3390/biology9120474 · Cited by 115
Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures
Loppnow, H., Zhang, L., Buerke, M., Lautenschläger, M., Chen, L., Frister, A., Schlitt, A., Luther, T., Song, N., Hofmann, B., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01036.x · Cited by 117
Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
Beckwitt, C. H., Shiraha, K., & Wells, A. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197422 · Cited by 121
Selected Pharmaceuticals in Different Aquatic Compartments: Part I—Source, Fate and Occurrence
Pereira, A. M. P. T., Silva, L. J. G., Laranjeiro, C. S. M., Lino, C. M., & Pena, A. (2020) · Molecules · doi:10.3390/molecules25051026 · Cited by 114
Scientific opinion on the safety of monacolins in red yeast rice
(ANS), E. P. O. F. A. A. N. S. A. T. F., Younes, M., Aggett, P. J., Aguilar, F., Crebelli, R., Dusemund, B., Filipič, M., Fernández, M. J. F., Galtier, P., Gott, D. M., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5368 · Cited by 110
The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins
Murphy, C., Deplazes, E., Cranfield, C. G., & Garcia, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228745 · Cited by 119
Statins attenuate outgrowth of breast cancer metastases
Beckwitt, C. H., Clark, A. M., Ma, B., Whaley, D., Oltvai, Z. N., & Wells, A. H. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0267-7 · Cited by 102
Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
Kumar, S. R., Grace, N. D., & Qamar, A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3179-2 · Cited by 101
Remediation of pharmaceuticals from contaminated water by molecularly imprinted polymers: a review
Zare‬, E. N., Fallah, Z., Le, V. T., Doan, V., Mudhoo, A., Joo, S., Vasseghian, Y., Tajbakhsh, M., Moradi, O., Sillanpää, M. E. T., et al. (2022) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01439-4 · Cited by 106
Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation
Dudhipala, N. R., & Veerabrahma, K. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.022 · Cited by 99
The differential effects of statins on the metastatic behaviour of prostate cancer
Brown, M. D., Hart, C. A., Tawadros, T., Ramani, V., Sangar, V., Lau, M., & Clarke, N. W. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.138 · Cited by 96
TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer
Torrealba, N., Vera, R., Fraile, B., Martínez-Onsurbe, P., Paniagua, R., & Royuela, M. (2019) · The Aging Male · doi:10.1080/13685538.2019.1597840 · Cited by 94
Statins alter neutrophil migration by modulating cellular Rho activity–a potential mechanism for statins-mediated pleotropic effects?
Maher, B. M., Dhonnchu, T. N., Burke, J. P., Soo, A., Wood, A. E., & Watson, R. W. G. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608382 · Cited by 93
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Sanfilippo, K. M., Keller, J., Gage, B. F., Luo, S., Wang, T., Moskowitz, G., Gumbel, J. H., Blue, B. J., O’Brian, K., & Carson, K. R. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.3482 · Cited by 92
The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments
Kaminski, R. M., Rogawski, M. A., & Klitgaard, H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0266-1 · Cited by 90
Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome
Hu, X., Li, H., Zhao, X., Zhou, R., Liu, H., Sun, Y., Fan, Y., Shi, Y., Qiao, S., Liu, S., et al. (2021) · Theranostics · doi:10.7150/thno.55946 · Cited by 89
Biochemistry of the non-mevalonate isoprenoid pathway
Gräwert, T., Groll, M., Rohdich, F., Bacher, A., & Eisenreich, W. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0753-z · Cited by 85
The effects of statins on dental and oral health: a review of preclinical and clinical studies
Tahamtan, S., Shirban, F., Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02326-8 · Cited by 86
Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: An in vitro study
Emani, S., Gunjiganur, G., & Mehta, D. S. (2014) · Contemporary Clinical Dentistry · doi:10.4103/0976-237x.137959 · Cited by 85
The Hippo Pathway in Prostate Cancer
Salem, O., & Hansen, C. G. (2019) · Cells · doi:10.3390/cells8040370 · Cited by 89
Adjusting for genetic confounders in transcriptome-wide association studies improves discovery of risk genes of complex traits
Zhao, S., Crouse, W. L., Qian, S., Luo, K., Stephens, M., & He, X. (2024) · Nature Genetics · doi:10.1038/s41588-023-01648-9 · Cited by 79
Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
Luo, G., Li, Z., Lin, X., Li, X., Chen, Y., Xi, K., Xiao, M., Wei, H., Zhu, L., & Xiang, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.001 · Cited by 84
Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats
Mahmoud, M. O., Aboud, H. M., Hassan, A. H., Ali, A. A., & Johnston, T. P. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.039 · Cited by 82
Therapeutic potential of herbal medicine for the management of hyperlipidemia: latest updates
Rauf, A., Akram, M., Anwar, H., Daniyal, M., Munir, N., Bawazeer, S., Bawazeer, S. S., Ребезов, М. Б., Bouyahya, A., Shariati, M. A., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19733-7 · Cited by 78
The Efficacy of Squalene in Cardiovascular Disease Risk-A Systematic Review
Ibrahim, N. ‘., Fairus, S., Zulfarina, M. S., & Naina Mohamed, I. (2020) · Nutrients · doi:10.3390/nu12020414 · Cited by 79
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
Zoungas, S., Curtis, A. J., Spark, S., Wolfe, R. S., McNeil, J. J., Beilin, L. J., Chong, T. T. ‐., CLOUD, G. C., Hopper, I., Kost, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069915 · Cited by 80
In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma
Kurakula, M., & Naveen, N. R. (2020) · Marine Drugs · doi:10.3390/md18040201 · Cited by 72
Pharmacogenetics of Statin-Induced Myotoxicity
Kee, P. S., Chin, P. K. L., Kennedy, M. A., & Maggo, S. D. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.575678 · Cited by 73
Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair
McNally, M. M., Agle, S. C., Parker, F. M., Bogey, W. M., Powell, C. S., & Stoner, M. C. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.01.028 · Cited by 72
Interdependence of Anti-Inflammatory and Antioxidant Properties of Squalene–Implication for Cardiovascular Health
Ibrahim, N. ‘., & Mohamed, I. N. (2021) · Life · doi:10.3390/life11020103 · Cited by 84
Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis
Derosa, G., Maffioli, P., Reiner, Ž., Simental‐Mendía, L. E., & Sahebkar, A. (2016) · Drugs · doi:10.1007/s40265-016-0591-2 · Cited by 70
Perspectives in anti-infective drug design. The late steps in the biosynthesis of the universal terpenoid precursors, isopentenyl diphosphate and dimethylallyl diphosphate
Rohdich, F., Bacher, A., & Eisenreich, W. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.05.012 · Cited by 71
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action
Yap, K. M., Sekar, M., Seow, L.-J., Gan, S. H., Bonam, S. R., Rani, N. N. I. M., Lum, P. T., Subramaniyan, V., Wu, Y. S., Fuloria, N. K., et al. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s316667 · Cited by 81
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Wilkinson, M. J., Lepor, N. E., & Michos, E. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028892 · Cited by 70
Biochemical characterization of Bacillus subtilis type II isopentenyl diphosphate isomerase, and phylogenetic distribution of isoprenoid biosynthesis pathways
Laupitz, R., Hecht, S., Amslinger, S., Zepeck, F., Kaiser, J., Richter, G., Schramek, N., Steinbacher, S., Huber, R., Arigoni, D., et al. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04194.x · Cited by 67
Role of Macrophages in Cardioprotection
Yap, J., Cabrera-Fuentes, H. A., Irei, J. S., Hausenloy, D. J., & Boisvert, W. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102474 · Cited by 72
Biosynthesis of isoprenoids
Gabrielsen, M., Rohdich, F., Eisenreich, W., Gräwert, T., Hecht, S., Bacher, A., & Hunter, W. N. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04234.x · Cited by 68
The Effect of Statin Medications on Perioperative and Long-Term Outcomes Following Carotid Endarterectomy or Stenting
Perler, B. A. (2007) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2007.10.008 · Cited by 68
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study
Kim, G., Jang, S., Han, E., Lee, Y., Park, S., Nam, C. M., & Kang, E. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30506 · Cited by 68
Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management
Marin, L., Colombo, P., Bebawy, M., Young, P. M., & Traini, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.588697 · Cited by 68
A mitochondrial NADPH-cholesterol axis regulates extracellular vesicle biogenesis to support hematopoietic stem cell fate
Bonora, M., Morganti, C., van Gastel, N., Ito, K., Calura, E., Zanolla, I., Ferroni, L., Zhang, Y., Jung, Y., Sales, G., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.02.004 · Cited by 70
Alzheimer’s Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways
Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204964 · Cited by 68
Regulatory T Cell Stability and Plasticity in Atherosclerosis
Ali, A. J., Makings, J., & Ley, K. (2020) · Cells · doi:10.3390/cells9122665 · Cited by 65
Metal–Organic Framework-Based Fluorescent Sensors for the Detection of Pharmaceutically Active Compounds
Ghosh, S., Rana, A., & Biswas, S. (2023) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c02459 · Cited by 66
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics
Brassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2022) · Clinical Science · doi:10.1042/cs20210835 · Cited by 72
Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis
Lacy, M., Atzler, D., Liu, R., de Winther, M. P. J., Weber, C., & Lutgens, E. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.012 · Cited by 69
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Galal, M. A., Al-Rimawi, M., Hajeer, A., Dahman, H., Alouch, S. S., & Aljada, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074083 · Cited by 73
Impact of avocado-enriched diets on plasma lipoproteins: A meta-analysis
Peou, S., Millard-Hasting, B. M., & Shah, S. A. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.10.011 · Cited by 63
Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
Jia, Y., Xu, R.-X., Sun, J., Tang, Y., & Li, J. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-103 · Cited by 58
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
Palandri, C., Santini, L., Argirò, A., Margara, F., Doste, R., Bueno‐Orovio, A., Olivotto, I., & Coppini, R. (2022) · Drugs · doi:10.1007/s40265-022-01728-w · Cited by 58
Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy
Mohammad, S., Nguyen, H., Nguyen, M., Abdel‐Rasoul, M., Nguyen, V., Nguyen, C. D., Nguyen, K. T., Li, L., & Kitzmiller, J. P. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180723120608 · Cited by 57
State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications
Azemawah, V., Movahed, M. R., Centuori, P., Penaflor, R., Riel, P. L., Situ, S., Shadmehr, M., & Hashemzadeh, M. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06904-x · Cited by 58
Potential Beneficial Effects of Vitamin D in Coronary Artery Disease
Legarth, C., Grimm, D. G., Krüger, M., Infanger, M., & Wehland, M. (2019) · Nutrients · doi:10.3390/nu12010099 · Cited by 58
A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment
Zhao, R., Ning, X., Wang, M., Wang, H., Xing, G., Wang, L., Lu, C., Yu, A., & Wang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02354 · Cited by 56
Progress in application of terahertz time-domain spectroscopy for pharmaceutical analyses
Huang, S., Deng, H., Wei, X., & Zhang, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1219042 · Cited by 56
Time‐dependent mediators in survival analysis: Modeling direct and indirect effects with the additive hazards model
Aalen, O. O., Stensrud, M. J., Didelez, V., Daniel, R., Røysland, K., & Strohmaier, S. (2019) · Biometrical Journal · doi:10.1002/bimj.201800263 · Cited by 60
Hempseed (Cannabis sativa) protein hydrolysates: A valuable source of bioactive peptides with pleiotropic health-promoting effects
Santos‐Sánchez, G., Álvarez‐López, A. I., Ponce‐España, E., Carrillo‐Vico, A., Bollati, C., Bartolomei, M., Lammi, C., & Cruz‐Chamorro, I. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.06.005 · Cited by 59
Systematic review of the in vitro effects of statins on oral and perioral microorganisms
Ting, M., Whitaker, E. J., & Albandar, J. M. (2015) · European Journal Of Oral Sciences · doi:10.1111/eos.12239 · Cited by 57
Influence of extraction methods of bay leaves (Syzygium polyanthum) on antioxidant and HMG-CoA Reductase inhibitory activity
Hartanti, L., Yonas, S. M. K., Mustamu, J. J., Wijaya, S., Setiawan, H. K., & Soegianto, L. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01485 · Cited by 63
A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management
Safitri, N., Alaina, M. F., Pitaloka, D. A. E., & Abdulah, R. (2021) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s333738 · Cited by 62
Contemporary Management of Dyslipidemia
Ferraro, R., Leucker, T. M., Martin, S. S., Banach, M., Jones, S. R., & Toth, P. P. (2022) · Drugs · doi:10.1007/s40265-022-01691-6 · Cited by 59
Effects of Atorvastatin on Angiogenesis in Hindlimb Ischemia and Endothelial Progenitor Cell Formation in Rats
Matsumura, M., Fukuda, N., Kobayashi, N., Umezawa, H., Takasaka, A., Matsumoto, T., Yao, E., Ueno, T., & Negishi, N. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no026 · Cited by 54
How lipids may affect risk for suicidal behavior
Daray, F. M., Mann, J. J., & Sublette, M. E. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.06.007 · Cited by 58
Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis
Cai, R., Yuan, Y., Zhou, Y., Xia, W., Wang, P., Sun, H., Yang, Y., Huang, R., & Wang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104922 · Cited by 53
Biochemistry of Statins
Egom, E. E. A., & Hafeez, H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.005 · Cited by 57
Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
Stefanutti, C. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00858-4 · Cited by 56
RHO GTPase Signaling for Axon Extension: Is Prenylation Important?
Samuel, F., & Hynds, D. L. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8144-2 · Cited by 53
Solubilization of simvastatin and phytosterols in a dilutable microemulsion system
Fisher, S., Wachtel, E. J., Aserin, A., & Garti, N. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.01.036 · Cited by 52
Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
Wang, H., Wang, Q., Wang, J., Guo, C., Kleiman, K., Meng, H., Knight, J. S., & Eitzman, D. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-14307-x · Cited by 51
The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
Zwartjes, M., Gerdes, V. E. A., & Nieuwdorp, M. (2021) · Metabolites · doi:10.3390/metabo11080531 · Cited by 52
Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats
Xu, Q., Liu, Y., Zhang, Q., Ma, B., Yang, Z., Liu, L., Yao, D., Cui, G., Sun, J., & Wu, Z. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.72 · Cited by 50
Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study
Ballantyne, C. M., Hoogeveen, R. C., Raya, J. L., Cain, V. A., Palmer, M. K., & Karlson, B. W. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.022 · Cited by 49
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage
Lakha, F., Τheodoratou, E., Farrington, S. M., Tenesa, A., Cetnarskyj, R., Din, F. V. N., Porteous, M. E., Dunlop, M. G., & Campbell, H. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-487 · Cited by 51

Authors: Stancu, C., & Sima, A.
Affiliations: Romanian Academy (RO)
Corresponding author: Sima, Anca
ORCID: Stancu, Camelia
Sima, Anca
Venue: Journal of Cellular and Molecular Medicine
Publisher: Wiley
Published: 2001-10
Volume: 5
Issue: 4
Pages: 378-387
ISSN: 1582-1838 (ISSN-L)
1582-4934
DOI: 10.1111/j.1582-4934.2001.tb00172.x
PMC: PMC6740083
OpenAlex: W2006572302
Cited by: 911
References: 42
Citations by year: 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
FWCI: 0.55
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2038 d)
Locations: Journal of Cellular and Molecular Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
MeSH terms: Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins: mechanism of action and effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks